IPC showcases India's Regulatory Excellence at WHO Meeting in Nepal (See 'Corp Brief') GI & Beyond 2.0 Summit showcases India's GI-tagged Handloom and Handicraft Products (See 'Corp Brief') IPR - Registration of defendant's trademark does not bar passing off action where plaintiff establishes prior goodwill, misrepresentation and likely damage: HC (See 'Legal Desk') CCI approves combination of many entities into InterGlobe Hotels (See 'Corp Brief') A&C - In international commercial arbitration seated in India, ground of ‘patent illegality' u/s 34(2A) is expressly excluded: HC (See 'Legal Desk') House Panel deliberates on strengthening Human-Wildlife Conflict Mitigation through Technology (See 'Corp Brief') Misc - A minor admitted to benefits of partnership firm is not personally liable for debts or liabilities incurred by firm during age of minority - ergo, bank communication declaring minor as wilful defaulter is invalid: HC (See 'Legal Desk') PM-PRANAM Promotes Balanced Use of Fertilizer, Organic Farming (See 'Corp Brief') On International Clouded Leopard Day, India strengthens Conservation through Dedicated Action Plan (See 'Corp Brief') Companies Act - Solely because a private bank carries on banking operations as scheduled bank or is bound to follow regulatory guidelines issued by the RBI, it does not acquires character of a statutory body: HC (See 'Legal Desk') C-DAC and GSI sign umbrella MoU to strengthen Geoscience & Mineral Exploration (See 'Corp Brief') IPR - Test for 'efficacy' u/s 3(d) of Patents Act is not limited to 'therapeutic efficacy' for all substances: HC (See 'Legal Desk') Dipka OC: Powering India's Growth through Scale & Efficiency (See 'Corp Brief') IPR - U/s 9(1)(a) of Trade Marks Act, correct legal test is whether applied mark possesses 'distinctive character', means if it is capable of distinguishing applicant's goods from those of others - YES: HC (See 'Legal Desk') Union Minister inaugurates Centre of Excellence for Handloom Technology at IIT Delhi (See 'Corp Brief') IBC - Private bank's commercial decision on debt assignment or settlement, even if regulated by RBI norms, remains private banking transaction and does not satisfy function test for writ maintainability: HC (See 'Legal Desk') Mandaviya felicitates Commonwealth Games 2026 Weightlifting medallists with cash rewards (See 'Corp Brief') Sonepur Bazari OCP: Setting New Benchmarks in Coal Production (See 'Corp Brief') IPR - In absence of evidence showing acquired distinctiveness or secondary meaning, descriptive mark could not validly remain on Register: HC (See 'Legal Desk') KCC-MISS has positively impacted Cropping Intensity and Multi-Season Cultivation (See 'Corp Brief') Disciplinary case pendency reduced from over 4,000 to 700: MoS (See 'Corp Brief') Limitation - Single Judge rightly declined to exercise writ jurisdiction in a matter which essentially involves contractual obligations & involves disputed issues of fact: HC (See 'Legal Desk') Handloom Hackathon 2.0 concludes at IIT Delhi (See 'Corp Brief') MoS reviews status of Ujh Multipurpose Project in Jammu & Kashmir (See 'Corp Brief') Exhibition open to visitors from 6 to 19 August (See 'Corp Brief') Tete-a-tete around AI in banking sector often begins with algorithms (See CORP EINSICHT) IBC - Insolvency cannot be used as substitute for debt recovery or to settle complicated shareholder battles: NCLT (See 'Legal Desk') Ministry of Textiles to celebrate 12 th National Handloom Day on 7 August (See 'Corp Brief') Railways approves Extension of Daily Ludhiana-Jakhal Passenger Train up to Jind (See 'Corp Brief') Catch the Rain in Odisha: From Awareness to Groundwater Recharge (See 'Corp Brief') IBC - Unregistered lease deed cannot be relied upon to establish substantive leasehold rights or duration of tenancy: NCLT (See 'Legal Desk')

Print

IPC showcases India's Regulatory Excellence at WHO Meeting in Nepal

Published: Aug 06, 2026

By TIOLCorplaws News Service

NEW DELHI, AUG 06, 2026: INDIAN Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare, Government of India participated in the 10th Anniversary Meeting of the South-East Asia Regulatory Network (SEARN) held in Kathmandu, Nepal, on 4-5 August 2026. The meeting brought together representatives of National Regulatory Authorities (NRAs), pharmacopoeias, and international organizations from across the South-East Asia Region to commemorate a decade of regional collaboration and to strengthen regulatory systems for ensuring the quality, safety and efficacy of medical products.

The SEARN is a collaborative platform established by the World Health Organization (WHO) South-East Asia Regional Office (SEARO) to strengthen regulatory systems across Member States. Since its inception in 2016, SEARN has facilitated cooperation among National Regulatory Authorities through knowledge sharing, regulatory convergence, capacity building, and reliance mechanisms. The network operates through thematic working groups focusing on key regulatory functions, including quality assurance, pharmacovigilance, clinical trials oversight, regulatory preparedness, and medical device regulation, with the shared objective of improving access to safe, effective and quality-assured medical products throughout the Region.

The IPC delegation comprised Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, Dr. Jai Prakash, Senior Principal Scientific Officer, Dr. Robin Kumar, Senior Principal Scientific Officer and Mr. Arvind Kumar Sharma, Scientific Officer.

During the meeting, IPC highlighted India's continued commitment to strengthening drug regulatory system and promoting access to quality-assured medicines through internationally harmonized standards. The delegation showcased the IPC's key initiatives in the development and publication of the Indian Pharmacopoeia, establishment of Indian Pharmacopoeia Reference Substances (IPRS) and Impurity Reference Standards (IMPRS), pharmacovigilance and materiovigilance activities under the Pharmacovigilance Programme of India (PvPI) and Materiovigilance Programme of India (MvPI), capacity-building programmes, and collaborative efforts with national and international stakeholders.

A significant milestone achieved during the meeting was the recognition of the IPC as the WHO-SEARN Regional Centre of Excellence in Pharmacovigilance and the Technical Centre in Quality. This prestigious recognition acknowledges IPC's sustained contributions to strengthening pharmacovigilance systems, advancing pharmaceutical quality standards, and supporting regulatory capacity-building across the WHO South-East Asia Region. The designation further reinforces IPC's role as a leader in pharmacopoeial science & standards and its commitment to promoting collaboration, knowledge sharing, and harmonization among Member States.

The meeting served as a valuable platform for exchanging scientific knowledge, sharing regulatory experiences, and discussing emerging challenges in pharmaceutical regulation, including quality assurance, safety, regulatory reliance, digital transformation, and regional cooperation. IPC reaffirmed its commitment to supporting collaborative initiatives that strengthen regulatory systems and improve public health outcomes across the South-East Asia Region.

IPC's participation in the 10th Anniversary Meeting of SEARN, coupled with its designation as the Regional Centre of Excellence in Pharmacovigilance and Technical Centre in Quality, marks another significant achievement in India's contribution to regional regulatory cooperation. The IPC remains committed to supporting WHO SEARN initiatives, fostering regulatory excellence, and ensuring the availability of safe, effective, and quality-assured medical products for the people of the South-East Asia Region.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.